HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of phenytoin therapy on the skin and skin disease.

Abstract
Phenytoin (diphenylhydantoin; Dilantin), ALZA Corp.) is a highly effective and widely prescribed anticonvulsant agent used in the treatment of focal and tonic clonic generalised seizures. The side effects of phenytoin can occassionally engender significant morbidity. Phenytoin can induce generalised eruptions that include: a maculopapular exanthem, Stevens-Johnson syndrome, generalised exfoliative dermatitis, toxic epidermal necrolysis, vasculitis and fixed drug eruptions. Phenytoin is linked to a hypersensitivity syndrome that manifests with fever, rash and lymphadenopathy. Patients receiving phenytoin may develop pseudolymphoma or, rarely, malignant lymphoma and mycosis fungoides-like lesions. Rarer cutaneous side effects include drug-induced lupus, purple hand syndrome, pigmentary alterations and IgA bullous dermatosis. Phenytoin can effect clotting function and alter vitamin and mineral levels. Prenatal exposure to phenytoin may result in a spectrum of structural, developmental and behavioural changes, known as the fetal hydantoin syndrome. Patients who use phenytoin in the long-term commonly manifest with gingival hyperplasia, coarsening of the facies, and hirsutism.
AuthorsNoah Scheinfeld
JournalExpert opinion on drug safety (Expert Opin Drug Saf) Vol. 3 Issue 6 Pg. 655-65 (Nov 2004) ISSN: 1744-764X [Electronic] England
PMID15500423 (Publication Type: Journal Article, Review)
Chemical References
  • Anticonvulsants
  • Minerals
  • Vitamins
  • Phenytoin
  • fosphenytoin
Topics
  • Abnormalities, Drug-Induced (etiology)
  • Adult
  • Anticonvulsants (adverse effects, pharmacokinetics, therapeutic use)
  • Child
  • Connective Tissue Diseases (chemically induced)
  • Drug Eruptions (etiology)
  • Drug Hypersensitivity (etiology)
  • Epilepsy (drug therapy)
  • Facies
  • Female
  • Gingival Hyperplasia (chemically induced)
  • Hirsutism (chemically induced)
  • Humans
  • Infant, Newborn
  • Lymphoma (chemically induced)
  • Male
  • Minerals (pharmacokinetics)
  • Phenytoin (adverse effects, analogs & derivatives, pharmacokinetics, therapeutic use)
  • Pregnancy
  • Pregnancy Complications (drug therapy)
  • Pseudolymphoma (chemically induced)
  • Vascular Diseases (chemically induced)
  • Vitamins (pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: